This article explores the history and implications of the FDA’s proposed rule classifying LTDs as devices under the Federal Food, Drug, and Cosmetic Act.
General Publications
October 2023
“Regulating Laboratory Developed Tests Back on FDA’s ‘Front Burner,’” Policy & Medicine Compliance Update, October 2023.
Media Contact